Tykerb is a drug licensed to treat metastatic breast cancer that has not responded to other treatments. This eMedTV page describes the effects of Tykerb, explains what to know before taking the drug, and lists possible side effects that may occur.
Common Tykerb side effects may include mouth sores, anemia, and nausea or vomiting. This eMedTV segment lists the most common side effects of the drug and also includes a list of potentially serious side effects that should be reported to a doctor.
Insomnia is a side effect that may occur with the use of Tykerb. This page of the eMedTV Web site further discusses the link between Tykerb and insomnia, explains how common the side effect is, and lists suggestions for improving sleep habits.
Tykerb is used for treating metastatic breast cancer in people who have not responded to other treatments. This eMedTV resource describes how the medication works and explains whether there are any off-label Tykerb uses.
The recommended Tykerb dosage for the treatment of breast cancer is 1250 mg a day. This article from the eMedTV Web site offers more detailed Tykerb dosing guidelines and provides suggestions for how and when to take the medication.
Medicines that may cause Tykerb drug interactions include nicardipine, repaglinide, and nefazodone. As this eMedTV article explains, these interactions can increase your risk of heart failure or an irregular heart rhythm called QT prolongation.
Tykerb can increase your risk of a life-threatening irregular heart rhythm called QT prolongation. This eMedTV article contains other Tykerb warnings and precautions, and offers information on who should not take the cancer medication.
If you take too much Tykerb, overdose symptoms may occur, such as vomiting or diarrhea. As this eMedTV article explains, the most appropriate treatment for a Tykerb overdose is not known, but supportive care may be the best option.
Taking Tykerb during pregnancy could be harmful to the unborn child. This section of the eMedTV library offers more information on Tykerb and pregnancy, and explains what complications may occur when a pregnant women takes the medicine.
In general, women are advised to stop breastfeeding if they are taking Tykerb. This eMedTV Web page discusses Tykerb and breastfeeding in more detail and explains the potential side effects or complications that may occur in the nursing infant.
Generic Tykerb will not be available in the United States until July 2017 at the earliest. As this eMedTV Web page explains, as soon as the patent for Tykerb expires, several drug companies are expected to begin manufacturing generic versions of it.
| Referring Pages | Articles |
